FDA Drug Application (020986) for NOVOLOG INNOLET by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number020986
Product Number004
FormINJECTABLE;SUBCUTANEOUS
Dosage300 UNITS/3ML (100 UNITS/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNOVOLOG INNOLET
Active IngredientINSULIN ASPART RECOMBINANT

Active IngredientCount
List of drugs with Active Ingredient INSULIN ASPART RECOMBINANT9


Back to FDA Applications sponsored by NOVO NORDISK INC